Crossmark

Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases

Crossref DOI link: https://doi.org/10.1007/s11882-018-0804-8

Published Online: 2018-08-31

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kaufman, Bridget P.

Alexis, Andrew F.
License Information

Text and Data Mining valid from 2018-08-31
More Information

Article History

First Online: 31 August 2018

Compliance with Ethical Standards

:

: Dr. Alexis reports personal fees from Pfizer and Sanofi-Genzyme/Regeneron; grants and personal fees from Galderma, Novartis, and Leo Pharma; and grants from Dermira, outside the submitted work. Dr. Kaufman reports personal fees from Sanofi-Genzyme/Regeneron, outside the submitted work.

: This article does not contain any studies with human or animal subjects performed by any of the authors.